Kiener Peter A 4
4 · Cue Biopharma, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Kiener Peter A
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-02+24,400→ 24,400 totalExercise: $0.34Exp: 2036-01-01→ Common Stock (24,400 underlying)
Footnotes (2)
- [F1]Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- [F2]This stock option becomes fully exercisable on the first anniversary of the grant date.